Image

Register Today!

Choose a topic from the drop-down menu to find a date & time that works best for you

Session 1: Emerging Evidence on Immunotherapy for Hepatocellular Carcinoma (HCC) Management in Early Stages
West Region: Tuesday, July 30, 2024 • 6:00–7:00 PM PT with Adam Burgoyne, MD, and Veeral Ajmera, MD, from UCSD
REGISTER NOW!>

Northeast Region: Tuesday, August 13, 2024 • 7:00–8:00 PM ET with Stacey Stein, MD
REGISTER NOW!>

Event Information

How Does It Work?

This brand-new, virtual 5-session series is designed to:

  • Educate the multidisciplinary HCC care team on the latest advances in the diagnosis and treatment of HCC and BTC with immunotherapy
  • Provide best practices for communicating with other team members and patients by providing access to specialists in academic centers to share best practices

Expert faculty from our regional partner institutions will lead the 60-minute consulting discussion sessions. Faculty teams will present lectures on the topic of HCC and BTC, followed by a robust discussion and mentoring around patient cases submitted by attendees.

All members of the multidisciplinary cancer team are welcome! Choose the date and time that works for you!

Why Should I Attend?

  • No cost to you or your team
  • Free CME credits available for participation—earn up to 5.0 credits!
  • Opportunities to present tough situations and receive feedback from a multidisciplinary team of specialists and peers

Meet the Experts

South Regional Chair

Amit Singal, MD
Medical Director of the Liver Tumor Program
Clinical Chief of Hepatology
Professor of Internal Medicine
UT Southwestern Medical Center
Dallas, TX

West Regional Chair

Adam Burgoyne, MD, PhD
Associate Clinical Professor
Department of Medicine
Division of Hematology/Oncology
University of California, San Diego
San Diego, CA

Midwest Regional Chair

Anjana Pillai, MD
Professor of Medicine
Associate Professor of Surgery
Co-Director, Living Donor Liver Transplant Program
Medical Director, Liver Tumor Program
Director, Transplant Hepatology Fellowship Program
UChicago Medicine
Chicago, IL

Northeast Regional Chair

Stacey M. Stein, MD
Associate Professor of Internal Medicine
Assistant Medical Director, Clinical Trials Office
Yale School of Medicine
New Haven, CT

CME Information

Program Overview/Target Audience

Program Overview:
A 5-meeting series designed to educate the multidisciplinary HCC care team on the latest advances in the diagnosis and treatment of HCC and BTC with immunotherapy and best practices for communicating with other team members and patients by providing access to specialists in academic centers to share best practices


Target Audience:
This educational activity is intended for medical oncologists, interventional oncologists/radiologists, hepatologists, pathologists, and allied health professionals (PAs, NPs, or nurses/nurse navigators, etc.) who are involved in the management of patients with liver cancer.

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA